CVS Sales Intelligence & Org Chart Report | Databahn

Talk to Sales

Call (844) 328-2224


CVS Health Org Chart: Corporate Structure, Board of Directors and Executive Leadership (2026)

As of November 11, 2026, CVS Health is led by David Joyner, Chairman and CEO, with Brian Newman as Executive Vice President and Chief Financial Officer and Michael F. Mahoney as Lead Independent Director. CVS Health Corporation reports four segments: Health Care Benefits (Aetna), Health Services (CVS Caremark and the health care delivery businesses), Pharmacy & Consumer Wellness (CVS Pharmacy) and Corporate/Other. On November 4, 2026, the company announced a plan to separate into two public companies by the first half of 2028: CVS Health, led by Joyner, and CVS Pharmacy, to be led by Prem Shah. This page draws on the Form 10-K for fiscal 2025, the Form 10-Q for the quarter ended September 30, 2026, the 2026 proxy statement, the November 4, 2026 earnings call and CVS Health announcement, and CVS Health's own leadership and board pages.

CVS Health key facts

Legal name CVS Health Corporation (Form 10-K, fiscal year ended Dec. 31, 2025, cover page)
State of incorporation Delaware (Form 10-K FY2025, cover page)
Headquarters One CVS Drive, Woonsocket, Rhode Island 02895 (Form 10-K FY2025, cover page)
Ticker and exchange CVS, New York Stock Exchange (Form 10-K FY2025, Item 5)
Fiscal 2025 total revenues $402.1 billion, up 7.8% from 2024 (Form 10-K FY2025, Item 7)
Q3 2026 total revenues $108.4 billion for the quarter ended Sept. 30, 2026, up 5.4%; $314.9 billion for the first nine months (Form 10-Q, Q3 2026)
Employees Over 300,000 colleagues as of Dec. 31, 2025, about 73% full-time (Form 10-K FY2025, Item 1, Human Capital)
Locations About 9,000 retail locations and more than 1,000 walk-in and primary care medical clinics as of Sept. 30, 2026 (Form 10-Q, Q3 2026, Note 1)
Members served 26.1 million medical members; about 87 million PBM plan members; an estimated 37 million people served through health insurance products, as of Sept. 30, 2026 (Form 10-Q, Q3 2026)
Reportable segments Health Care Benefits; Health Services; Pharmacy & Consumer Wellness; Corporate/Other (Form 10-Q, Q3 2026, segment note)
Planned separation Two independent public companies, CVS Health and CVS Pharmacy, expected in the first half of 2028, subject to final board approval, an effective Form 10 and tax confirmation (Form 10-Q, Q3 2026; CVS Health announcement, Nov. 4, 2026)

CVS Health corporate structure

CVS Health Corporation Woonsocket, Rhode Island (NYSE: CVS)
Health Care Benefits Aetna; principal office in Hartford, Connecticut
Commercial Insured and ASC (self-funded) plans
Government Medicare Advantage, Medicare Part D and Medicaid
Individual exchange Exited in 2026
Health Services Pharmacy benefit management and health care delivery
CVS Caremark PBM; 1.9 billion prescriptions filled or managed in 2025
CVS Specialty Specialty pharmacy
Mail pharmacy Mail order pharmacy services
Cordavis Biosimilar subsidiary working with manufacturers
Oak Street Health Value-based primary care for Medicare patients
Signify Health In-home health evaluations
MinuteClinic More than 800 U.S. locations
Pharmacy & Consumer Wellness CVS Pharmacy retail and infusion
CVS Pharmacy More than 7,000 retail stores, about 4% owned
Pharmacies in retail chains About 1,870, primarily in Target stores
Infusion services Compounding, specialty infusion and enteral nutrition branches
Corporate/Other Management, administrative and corporate functions
Planned separation, first half of 2028 Announced Nov. 4, 2026
CVS Health Health care solutions company; David Joyner, Chairman and CEO
Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health
CVS Pharmacy Retail pharmacy and community health care company; Prem Shah, CEO upon separation
Retail pharmacy, mail pharmacy, MinuteClinic (including virtual care) and the Health100 technology services business

Source: Form 10-K for fiscal year ended Dec. 31, 2025 (Items 1 and 2); Form 10-Q for quarter ended Sept. 30, 2026, filed Nov. 4, 2026 (segment descriptions and planned separation); CVS Health announcement, Nov. 4, 2026; CVS Specialty as named on CVS Health earnings calls.

CVS Health board of directors

J. David Joyner Chief Executive Officer and Chairman of the Board Executive (chair) Public Policy and External Affairs
Michael F. Mahoney Lead Independent Director of CVS Health Corporation and Chief Executive Officer, President and Chairman of Boston Scientific Corporation Nominating and Corporate Governance (chair) Management Planning and Development Executive
Fernando Aguirre Former Chairman, President and CEO of Chiquita Brands International, Inc. Audit (chair) Management Planning and Development
Jeffrey R. Balser, M.D., Ph.D. President and CEO of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine Health Services and Technology (chair) Audit Executive
C. David Brown II Partner and Former Member of the Executive Committee of Nelson Mullins Riley & Scarborough LLP Management Planning and Development (chair) Nominating and Corporate Governance Public Policy and External Affairs
Alecia A. DeCoudreaux President Emerita of the former Mills College, now Mills College at Northeastern University, and Former Executive at Eli Lilly and Company Health Services and Technology Nominating and Corporate Governance
Anne M. Finucane Chair of the Board of Rubicon Carbon and Former Vice Chairman of Bank of America Corporation Public Policy and External Affairs (chair) Management Planning and Development Executive
John E. Gallina Former Executive Vice President and Chief Financial Officer of Elevance Health, Inc. Audit
J. Scott Kirby Chief Executive Officer of United Airlines Holdings, Inc. Health Services and Technology Nominating and Corporate Governance
Leslie V. Norwalk Strategic Counsel at Epstein, Becker & Green, P.C. Health Services and Technology Public Policy and External Affairs
Guy P. Sansone Co-founder, Chairman and Chief Executive Officer of H2 Health Audit Nominating and Corporate Governance
Douglas H. Shulman Chairman and Chief Executive Officer of OneMain Financial Health Services and Technology Management Planning and Development
Teresa A. Heitsenrether Executive Vice President, Chief Data and Analytics Officer of JPMorgan Chase & Co. Elected to the board, effective Nov. 18, 2026

Source: CVS Health board of directors page (investors.cvshealth.com, accessed Sept. 30, 2026); committee assignments from the 2026 proxy statement (DEF 14A) for the May 14, 2026 annual meeting, with the Audit and Public Policy and External Affairs seats held by Larry M. Robbins shown as unfilled because no announcement of replacements has been made; Larry M. Robbins departure (Aug. 13, 2026) and Teresa A. Heitsenrether election (effective Nov. 18, 2026) from CVS Health's Aug. 17, 2026 announcement.

CVS Health executive leadership

David Joyner Chairman and CEO, CVS Health To lead CVS Health after separation
Brian Newman Executive Vice President and Chief Financial Officer, CVS Health
Prem Shah Executive Vice President and Group President, CVS Health CEO of CVS Pharmacy upon separation
Steve Nelson Executive Vice President and President, Aetna
Ed DeVaney Executive Vice President and President, Caremark
Len Shankman Executive Vice President and President, Pharmacy Services, CVS Health
Sree Chaguturu, MD Executive Vice President and President of Health Care Delivery
Siddharth Tenneti President of Pharmacy and Consumer Wellness, CVS Health
Katerina Guerraz Executive Vice President, CVS Health and Chief Operating Officer, Aetna and President of Medicaid, Aetna
Tilak Mandadi President, Health100 and EVP, Ventures and Chief Experience and Technology Officer
Amy Compton-Phillips, MD Executive Vice President and Chief Medical Officer, CVS Health
Sam Khichi Executive Vice President, Corporate Affairs and Chief Legal Officer
Heidi Capozzi Executive Vice President and Chief People Officer, CVS Health
James D. Clark Senior Vice President, Controller and Chief Accounting Officer

Source: CVS Health executive leadership team page (cvshealth.com, as of Nov. 11, 2026); Siddharth Tenneti appointment from Chain Drug Review, Oct. 28, 2026; Tilak Mandadi title from the leadership team page as of Nov. 11, 2026; separation roles from CVS Health's Nov. 4, 2026 announcement; James D. Clark from the Form 10-K for fiscal 2025 executive officer list and CVS Health investor relations. Reporting lines not disclosed in the filing.

What CVS Health's filings tell a seller

Strategic priorities

On November 4, 2026, CVS Health said it will separate into two public companies by the first half of 2028. Joyner gave four reasons on the earnings call: focus, capital allocation, agility and simplicity. He also said each company "will have greater flexibility to adopt the technologies that best fit its needs." The operating priorities from earlier in the year still hold: Aetna margin recovery, the Caremark move to net cost pricing models and the Health100 consumer platform. Sellers who can show which company their product serves, and why it matters on Day 1, give both future leadership teams something they can act on.

The full Databahn report ties each priority to the executive accountable for it, on both sides of the planned split.

What CVS Health's executives are paid to deliver

The 2025 annual bonus plan weighted adjusted operating income at 60%, the adjusted SG&A ratio at 20% and Net Promoter Score at 20%, and funded at 142.3%. The 2025 to 2027 performance shares weight three-year cumulative adjusted EPS at 70%, with the remaining 30% split evenly across debt paydown, the share of Medicare members in 4+ Star plans, and the share of customers using two or more CVS Health offerings. Sellers who can show movement on cost ratios, Stars or cross-enterprise customer counts are speaking to numbers that set executive pay.

The full Databahn report maps each metric to the leader who carries it and the conversation that opens it.

Spending and capital plans

CVS Health spent $2.36 billion on property and equipment in the first nine months of 2026. Management repeated a commitment to invest more than $20 billion in technology over the next decade, raised its 2026 cash flow from operations outlook to at least $15.5 billion, and plans to resume share repurchases in the fourth quarter after reaching its target leverage ratio ahead of schedule. The CFO called the one-time and stranded costs of the separation "manageable" and said the company will look to offset run-rate costs over time.

The full Databahn report shows where the technology dollars sit and which teams control them as the company divides.

Acquisitions, divestitures and the separation

Under the plan, CVS Health keeps Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health. CVS Pharmacy takes about 9,000 retail pharmacies, mail pharmacy, MinuteClinic and the Health100 technology services business. Management said the two companies will be tied by commercial agreements worked out over the next 15 to 18 months. Earlier deals still shape the picture: the 2025 purchase of certain Rite Aid prescription files and stores in Idaho, Oregon and Washington, the 2025 Omnicare deconsolidation, and ongoing integration costs for Oak Street Health and Signify Health. For a seller's view of the split, read One CVS, Two Buyers: The 18-Month Window Every Enterprise Tech Seller Needs to See, a Databahn Sales Intelligence Brief.

The full Databahn report maps which systems, contracts and leaders land on each side of the separation.

Technology and AI initiatives

On the November 4 call, Prem Shah said AI now supports pharmacy workflow for 85% of CVS prescriptions. Management called Health100, its AI-native consumer engagement platform, "the connective tissue between the 2 organizations" after the split, and both companies have committed to it. Aetna's AI-enabled Claims Assist Manager is expected to cut claims processing time by more than 20%, and 83% of Aetna prior authorizations are approved in real time. Tilak Mandadi now holds the title President, Health100 alongside his Chief Experience and Technology Officer role, and Jack Hanlon is Senior Vice President, AI & Analytics. Management describes the company as moving toward a consumer health care technology business.

The full Databahn report names the technology owners behind each program and how their remits divide.

Risk factors and pressure points

The Q3 10-Q adds a new risk: executing the separation "will require significant time and attention" from senior management and could disrupt the business. Management expects Health Services earnings to bottom out in 2027 at no less than $7 billion in adjusted operating income, citing a decline in the 340B business, "a less robust selling season and health plan client membership attrition". The 10-K still leads with the difficulty of forecasting health care costs. Vendors that lower separation risk, or help with cost forecasting and client retention, are working on problems the company has put in writing.

The full Databahn report ranks these pressures by business unit and links each to its owner.

How vendors get approved

CVS Health says it assesses the cybersecurity risk profiles of key third parties, and its own systems are assessed against HIPAA, NIST 800-53, SOC 1, SOC 2 Type 2, HITRUST, PCI DSS and National Association of Insurance Commissioners standards. A vendor holding SOC 2 Type 2 and HITRUST evidence before procurement asks for it shortens the review.

The full Databahn report outlines the review path and the people who sign off at each step.

Who owns security and data decisions

The Chief Information Security Officer reports to the Chief Experience and Technology Officer (Tilak Mandadi), who reports to the CEO. The board's Audit Committee, chaired by Fernando Aguirre, oversees cybersecurity, privacy and information governance and gets CISO and CETO briefings at least bi-quarterly. The Health Services and Technology Committee, chaired by Jeffrey R. Balser, reviews the technology and digital portfolio and how those assets are procured or developed.

The full Databahn report names the security, privacy and data leaders below the CETO.

Leadership changes

Siddharth Tenneti was named President of Pharmacy and Consumer Wellness in October 2026 after leading the business on an interim basis. With the separation, Joyner will lead CVS Health and Prem Shah will become CEO of CVS Pharmacy; CVS said other leadership positions and board members will be announced later. On the board, Larry M. Robbins left on August 13, 2026, and Teresa A. Heitsenrether was elected to the board effective November 18, 2026. Tilak Mandadi added the title President, Health100, and Jack Hanlon is Senior Vice President, AI & Analytics. Brian Newman became CFO on May 12, 2025. Two leadership teams forming over the next 18 months means new owners for many vendor relationships.

The full Databahn report tracks each change and what the new leader has said about priorities.

Systems and business transformations

The separation is now the main transformation. It requires a Form 10 registration statement, final board approval and commercial agreements between the two companies. The Q3 2026 10-Q reports no material change in internal control over financial reporting. Pricing models are also shifting: CVS Pharmacy uses cost-based reimbursement (CVS CostVantage), and Caremark is moving clients to net cost pricing.

The full Databahn report details the systems behind each transition and who sponsors them.

Shareholder pressure

The 2026 proxy carried a stockholder proposal to let holders of 10% of shares request a record date for action by written consent, down from the current 25%. The board recommended against it, noting stockholders rejected substantially identical proposals in 2021 and 2025. Management also reached out to holders of about 60% of outstanding stock in late 2025 and early 2026, partly to discuss the prior say-on-pay vote.

The full Databahn report explains how investor pressure shows up in this year's operating decisions.

Locations by territory

As of September 30, 2026, CVS Health ran about 9,000 retail locations and more than 1,000 walk-in and primary care medical clinics. At year-end 2025 that included about 1,870 pharmacies inside other retail chains and 246 leased primary care centers across 27 states. The headquarters complex in Woonsocket, Rhode Island covers about one million square feet, and Aetna's owned complex in Hartford, Connecticut covers about 1.7 million. The filings don't break store counts out by state.

The full Databahn report maps regional leadership to these footprints.

What management told analysts

On November 4, 2026, CVS Health raised 2026 adjusted EPS guidance to at least $8.20 and set total revenues at a minimum of $420 billion and cash flow from operations at a minimum of $15.5 billion. It set a 2027 adjusted EPS floor of $8.65 and said it now expects to land at the high end of its mid-teens adjusted EPS growth target through 2028. Formal 2027 guidance comes on the fourth quarter call in February 2027. Those are public commitments, so proposals that protect or add to them get attention.

The full Databahn report tracks each commitment by segment and the executive answering for it.

CVS Health org chart FAQ

Who is the CEO of CVS Health?

David Joyner is Chairman and CEO of CVS Health. He became CEO in October 2024 and added the board chair role on January 1, 2026.

Who is the CFO of CVS Health?

Brian Newman is Executive Vice President and Chief Financial Officer, effective May 12, 2025. He was previously CFO of United Parcel Service.

Who is on CVS Health's board of directors?

The board includes J. David Joyner (Chairman), Michael F. Mahoney (Lead Independent Director), Fernando Aguirre, Jeffrey R. Balser, C. David Brown II, Alecia A. DeCoudreaux, Anne M. Finucane, John E. Gallina, J. Scott Kirby, Leslie V. Norwalk, Guy P. Sansone and Douglas H. Shulman. Teresa A. Heitsenrether was elected to the board effective November 18, 2026.

How is CVS Health organized?

CVS Health reports four segments: Health Care Benefits (Aetna), Health Services (CVS Caremark and health care delivery, including Oak Street Health, Signify Health and MinuteClinic), Pharmacy & Consumer Wellness (CVS Pharmacy) and Corporate/Other.

What companies does CVS Health own?

CVS Health owns Aetna, CVS Caremark, CVS Specialty, CVS Pharmacy, Oak Street Health, Signify Health, MinuteClinic and Cordavis, its biosimilar subsidiary. It added certain Rite Aid prescription files and stores in Idaho, Oregon and Washington in 2025.

Who oversees cybersecurity at CVS Health?

The Chief Information Security Officer leads cybersecurity and reports to Tilak Mandadi, Chief Experience and Technology Officer, who reports to the CEO. The board's Audit Committee, chaired by Fernando Aguirre, oversees cybersecurity risk.

Who runs Aetna?

Steve Nelson is Executive Vice President and President, Aetna. Katerina Guerraz is Chief Operating Officer of Aetna and President of Medicaid.

Is CVS Health splitting into two companies?

Yes. On November 4, 2026, CVS Health announced a plan to separate into CVS Health (Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health) and CVS Pharmacy (retail and mail pharmacy, MinuteClinic and Health100). The separation is expected in the first half of 2028.

What's in the full Databahn report

  • How to position against the incumbent vendor in your category
  • Who to call, in what order, with verified contact details
  • The questions to ask each executive
  • The questions CVS Health is likely to ask you back

Request a custom sales intelligence report

Walk into your first CVS Health meeting knowing who decides, what they're measured on and what to say.

Let's get started